Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01367483 · ClinicalTrials.gov registry record · Phase 1
Study of the Pharmacokinetics of Intravenous Administered 14C-MNTX
A Phase 1 study of Healthy Male Volunteers, sponsored by Bausch Health Americas.
- Completed
- Registry status
- Phase 1
- Development phase
- 6
- Enrollment target
- 1
- Study location
NCT01367483 is a Phase 1 study of Healthy Male Volunteers that has completed, run by Bausch Health Americas. The registered enrollment target is 6 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01367483, a Phase 1 study of Healthy Male Volunteers, has completed, sponsored by Bausch Health Americas.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 6 participants
- Enrollment target
- 1
- Study location
Study Summary
This is an open-label, radiotracer study, to be conducted in healthy, normal, male volunteers. It will entail intravenous administration of a single dose of 14C-MNTX, collection of excretions, and periodic drawing of blood samples. Exhaled 14CO2 will also be sampled as a measure of the extent of possible metabolic MNTX demethylation.
Conditions Studied
Interventions
- DRUG IV methylnaltrexone (MNTX)
Study Locations (1)
New York
- Progenics Pharmaceuticals, Inc. - Tarrytown
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2005-06 |
| Est. Completion | 2005-06 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01367483
The ClinicalTrials.gov registry entry for NCT01367483 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bausch Health Americas, which has 168 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Healthy Male Volunteers appearing as the primary indexed condition, and to 1 intervention - of which IV methylnaltrexone (MNTX) is the first listed.
NCT01367483 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT01367483 about?
NCT01367483 is a clinical study titled "Study of the Pharmacokinetics of Intravenous Administered 14C-MNTX". This is an open-label, radiotracer study, to be conducted in healthy, normal, male volunteers. It will entail intravenous administration of a single dose of 14C-MNTX, collection of excretions, and periodic drawing of blood samples. Exhaled 14CO2 will also be sampled as a measure of the extent of pos...
What is the current status of trial NCT01367483?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 6 participants. The study started on 2005-06. Estimated completion is 2005-06.
What conditions does trial NCT01367483 study?
This clinical trial studies the following conditions: Healthy Male Volunteers.
What interventions are being tested in trial NCT01367483?
The interventions under investigation include: IV methylnaltrexone (MNTX) (DRUG).
Who is sponsoring clinical trial NCT01367483?
This trial is sponsored by Bausch Health Americas, which has 168 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01367483 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy Male Volunteers
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.